JFG
CAMP icon

Jefferies Financial Group’s CAMP4 Therapeutics CAMP Stock Holding History

Jefferies Financial Group’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,361
Closed -$69.6K – 1783
2025
Q4 		$69.6K Buy
+11,361
New +$48.3K ﹤0.01% 1738

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jefferies Financial Group's CAMP Position: Q1 2026 in Review

Jefferies Financial Group sold out of CAMP4 Therapeutics (CAMP) in Q1 2026, closing a stake of 11,361 shares — an estimated $69.6K sold.

Jefferies Financial Group first reported a position in CAMP in Q4 2025 and held it in 1 quarter. The position peaked at $69.6K in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Jefferies Financial Group reported no remaining CAMP4 Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 11,361 CAMP4 Therapeutics shares in Q1 2026, an estimated $69.6K.
  • Jefferies Financial Group first reported a position in CAMP4 Therapeutics in Q4 2025 and held it in 1 quarter.
  • Jefferies Financial Group's CAMP4 Therapeutics position peaked at $69.6K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.